424 related articles for article (PubMed ID: 26179095)
1. Evaluation of an Erns-based enzyme-linked immunosorbent assay to distinguish Classical swine fever virus-infected pigs from pigs vaccinated with CP7_E2alf.
Pannhorst K; Fröhlich A; Staubach C; Meyer D; Blome S; Becher P
J Vet Diagn Invest; 2015 Jul; 27(4):449-60. PubMed ID: 26179095
[TBL] [Abstract][Full Text] [Related]
2. The double-antigen ELISA concept for early detection of E
Meyer D; Fritsche S; Luo Y; Engemann C; Blome S; Beyerbach M; Chang CY; Qiu HJ; Becher P; Postel A
Transbound Emerg Dis; 2017 Dec; 64(6):2013-2022. PubMed ID: 28158921
[TBL] [Abstract][Full Text] [Related]
3. Two newly developed E(rns)-based ELISAs allow the differentiation of Classical Swine Fever virus-infected from marker-vaccinated animals and the discrimination of pestivirus antibodies.
Aebischer A; Müller M; Hofmann MA
Vet Microbiol; 2013 Jan; 161(3-4):274-85. PubMed ID: 22902189
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of chimeric Pestivirus vaccine candidates against classical swine fever: protection and DIVA characteristics.
Eblé PL; Geurts Y; Quak S; Moonen-Leusen HW; Blome S; Hofmann MA; Koenen F; Beer M; Loeffen WLA
Vet Microbiol; 2013 Mar; 162(2-4):437-446. PubMed ID: 23238022
[TBL] [Abstract][Full Text] [Related]
5. DIVA vaccine properties of the live chimeric pestivirus strain CP7_E2gif.
von Rosen T; Rangelova D; Nielsen J; Rasmussen TB; Uttenthal Å
Vet Microbiol; 2014 Jun; 170(3-4):224-31. PubMed ID: 24629779
[TBL] [Abstract][Full Text] [Related]
6. Enhanced expression of the Erns protein of classical swine fever virus in yeast and its application in an indirect enzyme-linked immunosorbent assay for antibody differentiation of infected from vaccinated animals.
Luo Y; Li L; Austermann-Busch S; Dong M; Xu J; Shao L; Lei J; Li N; He WR; Zhao B; Li S; Li Y; Liu L; Becher P; Sun Y; Qiu HJ
J Virol Methods; 2015 Sep; 222():22-7. PubMed ID: 26005003
[TBL] [Abstract][Full Text] [Related]
7. CP7_E2alf: a safe and efficient marker vaccine strain for oral immunisation of wild boar against Classical swine fever virus (CSFV).
Koenig P; Lange E; Reimann I; Beer M
Vaccine; 2007 Apr; 25(17):3391-9. PubMed ID: 17257713
[TBL] [Abstract][Full Text] [Related]
8. An avirulent chimeric Pestivirus with altered cell tropism protects pigs against lethal infection with classical swine fever virus.
Reimann I; Depner K; Trapp S; Beer M
Virology; 2004 Apr; 322(1):143-57. PubMed ID: 15063124
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of marker vaccine candidate CP7_E2alf against challenge with classical swine fever virus isolates of different genotypes.
Blome S; Gabriel C; Schmeiser S; Meyer D; Meindl-Böhmer A; Koenen F; Beer M
Vet Microbiol; 2014 Feb; 169(1-2):8-17. PubMed ID: 24411658
[TBL] [Abstract][Full Text] [Related]
10. Differentiation of classical swine fever virus infection from CP7_E2alf marker vaccination by a multiplex microsphere immunoassay.
Xia H; Harimoorthy R; Vijayaraghavan B; Blome S; Widén F; Beer M; Belák S; Liu L
Clin Vaccine Immunol; 2015 Jan; 22(1):65-71. PubMed ID: 25378351
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of CSF vaccine CP7_E2alf in piglets with maternally derived antibodies.
Eblé PL; Quak S; Geurts Y; Moonen-Leusen HW; Loeffen WL
Vet Microbiol; 2014 Nov; 174(1-2):27-38. PubMed ID: 25265929
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of marker vaccine candidate CP7_E2alf in piglets with maternally derived C-strain antibodies.
Rangelova D; Nielsen J; Strandbygaard B; Koenen F; Blome S; Uttenthal A
Vaccine; 2012 Oct; 30(45):6376-81. PubMed ID: 22939909
[TBL] [Abstract][Full Text] [Related]
13. Reduced specificity of E
Meyer D; Loeffen W; Postel A; Fritsche S; Becher P
Transbound Emerg Dis; 2018 Apr; 65(2):e505-e508. PubMed ID: 29314759
[TBL] [Abstract][Full Text] [Related]
14. Kinetics of maternally derived antibodies upon intramuscular vaccination against classical swine fever with Suvaxyn
Schröder C; Dräger C; Aebischer A; Dähnert L; Breidenstein C; Mamerow S; Leidenberger S; Beer M; Blome S
Vet Microbiol; 2016 Nov; 196():14-17. PubMed ID: 27939149
[TBL] [Abstract][Full Text] [Related]
15. CP7_E2alf oral vaccination confers partial protection against early classical swine fever virus challenge and interferes with pathogeny-related cytokine responses.
Renson P; Le Dimna M; Keranflech A; Cariolet R; Koenen F; Le Potier MF
Vet Res; 2013 Feb; 44(1):9. PubMed ID: 23398967
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of Suvaxyn CSF Marker (CP7_E2alf) in the presence of pre-existing antibodies against Bovine viral diarrhea virus type 1.
Dräger C; Schröder C; König P; Tegtmeyer B; Beer M; Blome S
Vaccine; 2016 Sep; 34(39):4666-4671. PubMed ID: 27523739
[TBL] [Abstract][Full Text] [Related]
17. Classical swine fever (CSF) marker vaccine. Trial I. Challenge studies in weaner pigs.
Uttenthal A; Le Potier MF; Romero L; De Mia GM; Floegel-Niesmann G
Vet Microbiol; 2001 Nov; 83(2):85-106. PubMed ID: 11557151
[TBL] [Abstract][Full Text] [Related]
18. Cytokine and immunoglobulin isotype profiles during CP7_E2alf vaccination against a challenge with the highly virulent Koslov strain of classical swine fever virus.
Renson P; Le Dimna M; Gabriel C; Levai R; Blome S; Kulcsar G; Koenen F; Le Potier MF
Res Vet Sci; 2014 Apr; 96(2):389-95. PubMed ID: 24530018
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of classical swine fever virus antibody detection assays with an emphasis on the differentiation of infected from vaccinated animals.
Schroeder S; von Rosen T; Blome S; Loeffen W; Haegeman A; Koenen F; Uttenthal A
Rev Sci Tech; 2012 Dec; 31(3):997-1010. PubMed ID: 23520753
[TBL] [Abstract][Full Text] [Related]
20. Towards licensing of CP7_E2alf as marker vaccine against classical swine fever-Duration of immunity.
Gabriel C; Blome S; Urniza A; Juanola S; Koenen F; Beer M
Vaccine; 2012 Apr; 30(19):2928-36. PubMed ID: 22406108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
